Literature DB >> 15591272

A protein truncating BRCA1 allele with a low penetrance of breast cancer.

B Gorski1, J Menkiszak, J Gronwald, J Lubinski, S A Narod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15591272      PMCID： PMC1735637          DOI： 10.1136/jmg.2004.019430

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  5 in total

1.  Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.

Authors:  J Gronwald; T Huzarski; B Byrski; K Medrek; J Menkiszak; A N Monteiro; P Sun; J Lubinski; S A Narod
Journal:  J Med Genet       Date:  2005-10-14       Impact factor: 6.318

2.  BRCA1 4153delA founder mutation in Russian ovarian cancer patients.

Authors:  Nadezhda Yu Krylova; Oksana S Lobeiko; Anna P Sokolenko; Aglaya G Iyevleva; Maxim E Rozanov; Natalia V Mitiushkina; Madina M Gergova; Tatiana V Porhanova; Adel F Urmancheyeva; Sergey Ya Maximov; Alexandr V Togo; Evgeny N Imyanitov
Journal:  Hered Cancer Clin Pract       Date:  2006-09-15       Impact factor: 2.857

Review 3.  The contribution of BRCA1 and BRCA2 to ovarian cancer.

Authors:  Susan J Ramus; Simon A Gayther
Journal:  Mol Oncol       Date:  2009-02-10       Impact factor: 6.603

4.  Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.

Authors:  Grigorijs Plakhins; Arvids Irmejs; Andris Gardovskis; Signe Subatniece; Santa Rozite; Marianna Bitina; Guntars Keire; Gunta Purkalne; Uldis Teibe; Genadijs Trofimovics; Edvins Miklasevics; Janis Gardovskis
Journal:  BMC Med Genet       Date:  2011-10-27       Impact factor: 2.103

5.  Principles of genetic predisposition to malignancies.

Authors:  Tadeusz Debniak; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.